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Abstract
Background: Recent developments enable to deliver rotational IMRT with standard C-arm gantry based linear
accelerators. This upcoming treatment technique was benchmarked in a multi-center treatment planning study
against static gantry IMRT and rotational IMRT based on a ring gantry for a complex parotid gland sparing head-
and-neck technique.
Methods: Treatment plans were created for 10 patients with head-and-neck tumours (oropharynx, hypopharynx,
larynx) using the following treatment planning systems (TPS) for rotational IMRT: Monaco (ELEKTA VMAT solution),
Eclipse (Varian RapidArc solution) and HiArt for the helical tomotherapy (Tomotherapy). Planning of static gantry
IMRT was performed with KonRad, Pinnacle and Panther DAO based on step&shoot IMRT delivery and Eclipse for
sliding window IMRT. The prescribed doses for the high dose PTVs were 65.1Gy or 60.9Gy and for the low dose
PTVs 55.8Gy or 52.5Gy dependend on resection status. Plan evaluation was based on target coverage, conformity
and homogeneity, DVHs of OARs and the volume of normal tissue receiving more than 5Gy (V5Gy). Additionally, the
cumulative monitor units (MUs) and treatment times of the different technologies were compared. All evaluation
parameters were averaged over all 10 patients for each technique and planning modality.
Results: Depending on IMRT technique and TPS, the mean CI values of all patients ranged from 1.17 to 2.82; and
mean HI values varied from 0.05 to 0.10. The mean values of the median doses of the spared parotid were 26.5Gy
for RapidArc and 23Gy for VMAT, 14.1Gy for Tomo. For fixed gantry techniques 21Gy was achieved for step&shoot
+KonRad, 17.0Gy for step&shoot+Panther DAO, 23.3Gy for step&shoot+Pinnacle and 18.6Gy for sliding window.
V5Gy values were lowest for the sliding window IMRT technique (3499 ccm) and largest for RapidArc (5480 ccm).
The lowest mean MU value of 408 was achieved by Panther DAO, compared to 1140 for sliding window IMRT.
Conclusions: All IMRT delivery technologies with their associated TPS provide plans with satisfying target coverage
while at the same time respecting the defined OAR criteria. Sliding window IMRT, RapidArc and Tomo techniques
resulted in better target dose homogeneity compared to VMAT and step&shoot IMRT. Rotational IMRT based on C-
arm linacs and Tomotherapy seem to be advantageous with respect to OAR sparing and treatment delivery
efficiency, at the cost of higher dose delivered to normal tissues. The overall treatment plan quality using Tomo
seems to be better than the other TPS technology combinations.
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Today intensity-modulated radiation therapy (IMRT) is
the method of choice for the treatment of patients with
complex-shaped planning target volumes (PTV) targets,
especially when concave targets are close to a larger
number of organs-at-risk (OAR) with different dose
constraints and for multiple integrated targets with dif-
ferent dose prescriptions e.g. simultaneous integrated
boost (SIB) treatments. The advantage of IMRT for
head-and-neck cancer patients is the dose reduction in
the parotid glands which implies less xerostomia and
therefore has a big impact on the quality of life. Besides
all these advantages of IMRT there are some disadvan-
tages too. The delivery of complex plans with traditional
IMRT techniques takes extra time and the dose distribu-
tion in the PTV is more inhomogeneous compared to
conformal techniques. Another important aspect is the
higher number of monitor units (MU) in comparison
with non-wedged conformal plans. These higher num-
bers of MUs result in increased peripheral dose, which
adds to the generally increased low dose region when
applying IMRT [1-3]. Different factors that influence the
quality and the complexity of IMRT plans have been
investigated by various authors [4-10].
Furthermore, there are some extra requirements for
the delivery of IMRT, for instance the high mechanical
and dosimetric accuracy of the treatment machine and a
TPS with a powerful optimisation and segmentation
algorithm.
During the last years new rotational IMRT treatment
technologies have become available. These technologies
utilize a higher number of degrees of freedom for dose
sculpting, i.e. the beam is on during gantry rotation, and
at the same time gantry speed, leaf positions, leaf speed
and dose rate may be varied. Helical tomotherapy (HT)
(Tomotherapy) and rotational IMRT techniques like
volumetric-modulated arc therapy (VMAT/Elekta) or
RapidArc (Varian) are the most prominent examples.
These new technologies enable to achieve treatment
plans of similar or better quality compared to static
IMRT [11-25]. VMAT and RapidArc can be delivered
with standard C-arm gantry linacs. Several authors
investigated the plan quality and other parameters in
comparisons of these new IMRT modalities with HT or
standard IMRT with fixed gantry angles.
Although several papers were published on comparing
static with rotational IMRT, they were limited mostly to
two treatment planning systems and were usually per-
formed in one institution, i.e. they were limited by plan-
ning traditions. To overcome this limitation it was the
aim of the present study to benchmark as many upcom-
ing rotational IMRT techniques as possible against a
wide range of commonly practised static IMRT and
dynamic IMRT techniques using one of the most com-
plex treatment situations in today’s clinical practice, a
parotid gland sparing head-and-neck technique with
simultaneous integrated boost (SIB). The influence of
different optimisation algorithms (3 different algorithms
for step&shoot) was integral part of this multi-institu-
tional study, but the influence of the dose calculation
algorithms was not taken into account for current
comparison.
Methods
Patients
Ten patients with complex shaped targets in the head-
and-neck region (orpharynx, hypopharynx, larynx) suita-
ble for an SIB technique were selected for this retro-
spective multi-centre treatment planning study. The
characteristics of these patients are shown in Table 1.
Treatment techniques
All PTVs and OARs were contoured in one TPS at the
study coordination centre in Jena. CT data including
structure sets of all patients were transferred to different
centres which provided one of the following treatment
technologies: Tomotherapy, VMAT, RapidArc, sliding
window and step&shoot IMRT. More specifically, the
following TPS were used: the TPS HiArt (Tomotherapy)
was used for the helical tomotherapy (Tomo); rotational
IMRT (VMAT) for an ELEKTA linac was planned with
the TPS Monaco while rotational IMRT performed with
a Varian linac (RadpidArc) was planned with Eclipse.
For the static gantry IMRT four TPS were used: for
step&shoot IMRT the KonRad (Siemens) system, the
TPS Pinacle (ADAC) and the Panther DAO (Prowess),
and finally for sliding window IMRT the Eclipse (Var-
ian) system. All treatment plans were calculated with a
nominal energy of 6 MV. The detailed overview about
the used technologies, the TPS, linac e.t.c. is shown in
table 2.
The aim of the planning study was to achieve similar
median doses in the PTVs for all ten patients. Depen-
dent on the therapy concept which is based on the sta-
tus of resection, the prescribed median PTV dose was
defined as 52.2Gy or 55.8Gy to the lymph node region
(PTV2) and as 60.9Gy or 65.1Gy to the integrated boost
volume (PTV1). The minimal criterium (93% of the pre-
scribed dose to minimal 99% of the PTV) was deduced
from the RTOG H0022 protocol. The maximum dose
criterion was defined as maximal 1% of the PTV
receives maximal 110%. Additionally, the OAR objective
for the parotid glands (Dmedian < 26Gy), for the mandib-
ular (Dmedian < 45Gy) and the spinal cord plus a 7 mm
margin (Dmax < 43Gy) should be satisfied. Fulfilling of
the dose criteria for the PTV is given highest priority
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cord could not be met.
Treatment plan evaluation
All doses in the evaluation are relative doses, normalised
to the prescribed doses of PTV1 and PTV2. The evalua-
tion was based on several criteria. The first criterium was
the PTV coverage with 93% of the prescribed dose. The
conformation of the PTVs (with respect to 93% of the
prescribed dose) was described by the conformity index
(CI = Volume93%/PTV). This specific formula was
selected based on the assumption that no more than 1%
of any PTV should receive <93% of its prescribed dose as
minimum criteria, i.e. almost 100% of the PTV should
received at least 93% of the dose. Target dose heteroge-
neity was described by the homogeneity index (HI=[D5%-
D95%]/Dmean), i.e. a small HI indicates a better plan in the
comparison. Another main focus of the comparison was
put on the DVHs of the OARs and the volume of healthy
tissue receiving more than 5Gy (V5Gy). Finally, the cumu-
lative monitor units (MUs) and treatment times of the
different technologies were compared. For that purpose
the different linac calibrations conditions were normalised
except the Tomotherapy machine.
All evaluation parameters were averaged over the 10
patients for each technique and planning modality.
The standard deviations for all evaluation values were
calculated over the ten patients.
Results
All IMRT technologies with their respective TPSs were
able to provide treatment plans which fulfilled the plan-
ning goals. Figure 1 shows as an example DVHs for one
patient for both PTVs and all IMRT techniques. The
coverage of the PTVs is seen in figure 2 and 3. In that
figures the doses which is given to 99% of the PTVs is
used as criterium. These doses are in a range of 91% till
95% of the prescribed dose for PTV1 and between 84%
and 93% for the PTV2.
The median doses of the low and high dose PTVs are
in a range of 99.9% (Tomo) and 104.9% (VMAT) for
PTV2 and between 101.4% (Konrad) and 105.8%
(VMAT) for PTV1 as seen in figure 4 and figure 5.
Conformation evaluation
Figure 6 and figure 7 show the CI values. The best con-
formation was achieved with the KonRad+step&shoot
w i t ham e a nC Io f1 . 1 7f o rt h eP T V 2 .T h eC Iv a l u e so f
the PTV2 were rather similar with 1.30 for sliding win-
dow, 1.31. for Tomo, 1.32 for DAO+step&shoot and
1.33 for Pinacle+step&shoot, while it was 1.38 for both
VMAT and RapidArc.
Table 1 Overview of the patients
Patient Nr Cancer type TNM stage Volume PTV1 Volume PTV2 Type
in ccm in ccm
Patient 1 Oropharynx-Ca pT4 N1cM0 169 617 Postoperative RT
Patient 2 Hypopharynx-Ca cT3 cN2a M0 327 989 Primary RT
Patient 3 Larynx-Ca T4 N2c M0 200 1568 Primary RT
Patient 4 Oropharynx-Ca pT4 pN2a M0 145 408 Postoperative RT
Patient 5 Oropharynx-Ca pT4a pN1 cM0 164 709 Postoperative RT
Patient 6 Oropharynx-Ca T3 N1 M0 279 881 Primary RT
Patient 7 Oropharynx-Ca pT4 N3 M0 166 768 Primary RT
Patient 8 Larynx-Ca pT3 N2 M0 151 851 Primary RT
Patient 9 Oropharynx-Ca cT4cN3 M0 338 850 Primary RT
Patient 10 Oropharynx-Ca pT4 pN2c cM0 235 1577 Postoperative RT
Table 2 Overview of used technologies, TPS and versions, linacs, number of beams or arcs and energy
technology TPS version linear accelerator number of arcs/beams energy algorithm
S&S Konrad 2.2.23 Siemens Oncor 11 beams 6 MV Pencil Beam
S&S Panther DAO 4.71 Siemens Artiste 11 beams 6 MV Pencil Beam
S&S Pinnacle 8.0 m Siemens Oncor 11 beams 6 MV Pencil Beam
SW Eclipse 8.1 Varian Clinac 1600 7 beams 6 MV Pencil Beam
VMAT Monaco 2.0.1 Elekta Synergy MLCi 2 arcs 6 MV Monte Carlo XVMC
Tomotherapy Hi-Art 3.1.4.7 Tomotherapy Hi-Art ——————————— 6 MV collapsed cone
Rapid Arc Eclipse 8.9 Varian Clinac 2300 2 arcs 6 MV AAA
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Figure 1 The prescribed doses are 55.8 Gy to the low dose region and 65.1Gy to the high dose region. The PTV2 is a subset of PTV1.
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Figure 2 Dose at 99% of the PTV2 dependend on technology and TPS.
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Page 4 of 10The conformation of the PTV1 was again best for
KonRad+Step&shoot (1.33). The second best result was
achieved by the sliding window technique and Tomo
(both 1.47), followed by RapiArc (1.63), DAO+step&-
shoot (1.68), VMAT (1.94) and Pinacle+step&shoot only
with 2.82.
Homogeneity evaluation
The HI values for PTV2 were not evaluated because not
all TPS were able to provide PTV2 excluded the Boost
P T V .H Iv a l u e sf o rP T V 1a r es h o w ni nf i g u r e8 .T h e
best HI for the PTV1 was found with Tomo (0.047), fol-
lowed by sliding window (0.062). Higher HI values were
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Figure 3 Dose at 99% of the PTV1 dependend on technology and TPS.
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Figure 4 Median doses of the PTV2 dependend on technologie and TPS.
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Page 5 of 10found for RapidArc (0.078) and DAO+step&shoot
(0.083), VMAT (0.091) treatment plans, as well as for
KonRad+step&shoot and Pinacle+step&shoot plans
(both 0.100).
Evaluation of OAR sparing
A summary of the results concerning OAR sparing is
s h o w ni nt a b l e3 .N o ta l lT P Sc o u l dr e a c ht h eO A R
objectives. The median doses of the parotids were
14.1Gy for Tomo, 17.0 Gy for step&shoot+DAO, 18.6Gy
for sliding window, 21Gy for step&shoot+KonRad, 23Gy
for VMAT, 23.3 Gy for step&shoot+Pinnacle and 26.5.
Gy for RapidArc.
The maximal doses to the myelon plus 7 mm margin
varied between 34.2Gy (Tomo), 40.6Gy (VMAT), 42 Gy
(RapidArc), 42.4 Gy (step&shoot+DAO), 42.9Gy (Kon-
Rad+step&shoot), 43.2 Gy (Pinnacle+step&shoot), to
44.9 Gy (sliding window).
The median doses to the mandible were 36.1Gy
(Tomo), 39.5 (Pinnacle+step&shoot), 40Gy (KonRad
Siemens Oncor
Pinnacle/step&shoot
Rapid Arc
Eclipse/dynamic
Elekta MLCi
Monaco2.1/VMAT
Thomotherapy
Hi-Art/dynamic
Varian Clinac
Eclipse/Sliding Window
Siemens Artiste
Prowess 
Panther/Step&Shoot
Siemens Oncor
KonRad/Step&Shoot
80,00
85,00
90,00
95,00
100,00
105,00
110,00
R
e
l
.
 
D
o
s
e
 
i
n
 
%
Figure 5 Median doses of the PTV1 dependend on technologie and TPS.
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Figure 6 Conformity index of the PTV2 dependend on technologie and TPS.
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Page 6 of 10+step&shoot), 41.2Gy (RapidArc), 42.9Gy (step&shoot
+DAO), 43.1Gy (VMAT), 43.7Gy (sliding window).
Evaluation of low dose burden, MUs and treatment time
Table 4 summarized the results of the volume receiving
more than 5Gy (V5Gy), the MU and treatment time,
respectively. The lowest V5Gy values were achieved with
the sliding window technique with fixed gantry angles
(3499 ccm). The other technologies present the follow-
ing values in increasing order: VMAT (4498 ccm), Kon-
Rad+step&shoot (4525 ccm), Pinacle+step&shoot (5010
ccm), Tomo (5122 ccm), DAO+step&shoot (5332 ccm)
and RapidArc (5480 ccm).
The comparison of the MUs for the different technol-
ogies showed a wide range. The normalised MUs
were lowest for DAO+step&shoot (408), followed by
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Figure 7 Conformity index of the PTV1 dependend on technologie and TPS.
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Figure 8 Homogeneity index of the PTV1 dependend on technologie and TPS.
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Page 7 of 10RapidArc (437) and VMAT (501). The step&shoot tech-
nique planned with KonRad required on average 800
MU, but when planned with Pinnacle it increased up to
1059 MU on average. The sliding window technique
needs on average 1140 MU for IMRT delivery.
The shortest mean treatment times were associated
with RapidArc (2.5 min with 2 arcs), followed by DAO
+step&shoot (7 min), Tomo (8 min), VMAT (9 min
with 2 arcs), sliding window (10.5 min) and step&shoot
with KonRad and Pinnacle (11 min).
Discussion
The present study is a multi-institutional study; this
implies that there are some “subjective” factors
depending on planning philosophy of the respective
hospital e.g. number of beam directions, number of
segments and arcs, limitations of the MLCs, weighting
of the importance of PTV and OAR. Another role
plays the level of experience of the planners in the dif-
ferent centres that’s why we selected for every technol-
ogy and TPS combination experienced users. But in
the last consequence the results of this multi-institu-
tional study show that all used IMRT technologies
together with their TPSs have the power to provide
treatment plans with a satisfying target coverage while
at the same time respecting the defined OAR criteria.
At least there is no best technology with respect to all
evaluation parameters, i.e. all techniques are connected
with some advantages and with some disadvantages. As
far as treatment planning is concerned, there were sub-
stantial differences in terms of usability to specify the
planning goals for the different volumes. It would be of
great help for treatment planning if functions where
available in TPS that excluded intersections automati-
cally or where priorities to different PTVs with inter-
sections could be assigned.
The results are in good agreement with published data
[26-29] regarding the volumatric arc therapy. Only the
results of our study getting with sliding window are
much better than in [17]. A differentiation of the
patients in the two groups (post-operative patients and
primary RT) did not show significant differences in the
results.
All treatment plans offer a very good coverage of the
PTV1 and a good coverage of the PTV2. The lowest
dose to the PTV2 with clearly inferior results com-
pared to the other techniques was achieved with the
Pinnacle step&shoot combination. The median doses
for the PTV2 and the PTV1 were in a range between
100% and 106%. This implies that the planners of the
participating institutes improved the coverage of the
PTVs with the help of an increase of the median dose.
The requirements demanded by the HR0022 protocol
are more or less fulfilled. ICRU recommendations for
prescribing, reporting and recording IMRT have just
been which will be helpful in the future to harmonize
IMRT practice [30].
Sliding window, RapidArc and Tomo techniques
resulted in better target dose homogeneity for the PTV1
compared to VMAT and step&shoot with Panther
DAO, Pinnacle and KonRad.
All technologies TPS combinations fulfill the OAR
constrains. Only the high myelon maximal dose receiv-
ing with sliding window is demonstrative (but with a
margin of 7 mm clinically acceptable). The highest med-
ian dose to the spared parotid while using the RapiArc
is peculiar too.
The volume which receives equal or more than 5Gy is
lowest with the sliding window technique (3800 ccm),
followed by the VMAT and KonRad step&shoot (about
4500 ccm). Pinnacle step&shoot, Tomo, Panther DAO
and RapidArc deliver doses of equal or more than 5Gy
Table 3 OAR doses dependend on IMRT technology
KonRad/S&S Panther DAO/S&S Eclipse/SW VMAT Tomotherapy Rapid Arc Pinnacle/S&S
myelon max.dose/Gy 42.34 ± 0.59 42.43 ± 0.50 44.89 ± 3.59 40.64 ± 1.58 34.25 ± 2.69 41.98 ± 0.26 43.17 ± 0.52
parotides median dose/Gy 21.01 ± 4.59 17.24 ± 2.97 18.68 ± 4.29 22.98 ± 4.41 14.11 ± 2.37 26.47 ± 5.31 22.46 ± 3.62
mandible median dose/Gy 39,99 ± 8,65 42,90 ± 7,19 43,70 ± 8,48 43,12 ± 9,51 36,14 ± 9,77 41,21 ± 8,98 39,50 ± 5,71
Table 4 MUs, treatment time, V5Gy dependend on IMRT technology
KonRad/S&S Panther DAO/
S&S
Eclipse/SW VMAT Tomotherapy Rapid Arc Pinnacle/S&S
MU normalised 800.44 ± 100.90 408.27 ± 17.97 1139.86 ±
239.45
500.82 ± 71.59 × 436.92 ± 36.53 1059.63 ±
134.85
treatment time/
min
11.18 ± 2.64 7.07 ± 0.72 10.5 ± 1.00 11.8 ± 1.44 7.74 ± 0.80 2.48 ± 0.01 11 ± 0.45
Volume/ccm 4524.94 ±
1969.67
5331.76 ±
1437.55
3802.11 ±
899.31
4497.85 ±
1196.30
5122.01 ±
1647.57
5479.37 ±
1524.97
5010.46 ±
1149.93
receiving >5 Gy
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Page 8 of 10to volumes of 5000 ccm or bigger. It is of interest that
neither the “classic IMRT” with fixed gantry angles nor
the rotation based IMRT is clearly the superior solution.
It seems that rotational IMRT techniques do not auto-
matically generate more volume that receives dose of
equal or more than 5Gy. The volume could probably
be even further reduced using higher photon beam
energies.
The treatment delivery times obtained in the present
s t u d yw e r es h o r t e s tf o rt h eR a p i d A r cs o l u t i o n .T h e
delivery times for Tomo and Panther DAO were in the
medium range while VMAT, step&shoot with Konrad
or Pinnacle and with sliding window were characterised
by the longest ones. As far as the VMAT results on
delivery efficiency are concerned, it needs to be empha-
sized that Monaco Version 2.01 was used in the present
study, which was improved recently with a new sequen-
cer available in successive versions of this TPS.
T h eM U sa r es i g n i f i c a n t l yr e d u c e df o rt h eD A O
step&shoot (408MU), RapidArc (437MU) and VMAT
(501MU). The MUs needed for a step&shoot KonRad
plan is situated in the centre (about 800MU). Pinnacle
step&shoot needs 1060MU and sliding window takes
the highest number of 1140MU. It is known that the
number of MU is one factor which influences the per-
ipheral dose, but there are some other factors like the
linac head shielding and collimation system (shape,
thickness, material), the focus body distance and the
spectrum of the beam. The peripheral dose is of impor-
tance without any doubt but in the particular case sub-
ordinated relativ to the treatment plan quality.
Conclusions
This is the first multi-institutional study that determined
the influence of seven different combinations of treat-
ment technologies and TPS combinations for the
planning of head and neck cancer treatments for a
simultaneous integrated boost technique. The results
presented above indicate that all IMRT delivery technol-
ogies with their associated TPS provide IMRT plans
with satisfying target coverage while at the same time
mostly respecting the defined OAR criteria.
Sliding window, RapidArc and Tomo techniques pro-
vide better target dose homogeneity compared to
VMAT and step&shoot with Panther DAO, Pinacle and
KonRad. The conformity reached was best for KonRad
f o rh i g ha n dl o wd o s eP T Vw i t har e m a r k a b l ed i s t a n c e
to the all other IMRT techniques. The overall treatment
plan quality using Tomo regarding target coverage, HI,
CI and OAR sparing seems to be better than the other
TPS technology combinations. For the parotid gland
clear median dose differences were observed for the dif-
ferent IMRT techniques. Rotational IMRT and Tomo
seem to be advantageous with respect to OAR sparing
sometimes and treatment delivery efficiency, at the cost
of higher dose burden (>5Gy) to normal tissues. The
application times are shortest for RapidArc with some
concessives e.g. parotid sparing. The combination of
Panther DAO and step&shoot shows that a segmenta-
tion algorithm which is optimised for time saving appli-
cations reduces the treatment time with plan quality
concessions too. The applications need the most time
with VMAT, with step&shoot with Konrad or Pinacle
and with sliding window.
We expect a medical relevance of the results of our
study e.g. partial underdosage, different OAR sparing,
dose burden with 5Gy or more; but this should be
investigated in prospective studies.
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